OmniAb (OABI) Revenue (2022 - 2026)

OmniAb (OABI) reported Revenue of $14.4 million for Q1 2026, up 247.3% year-over-year from $4.2 million in Q1 2025, and up 72.24% quarter-over-quarter from $8.4 million in Q4 2025.

OmniAb (OABI) Revenue (2022 - 2026) Analysis & Trends

OmniAb (OABI) has 5 years of Revenue data on file, last reported at $14.4 million in Q1 2026.

  • Revenue for Q1 2026 came in at $14.4 million, up 247.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.9 million (up 8.21% YoY), and the FY2025 annual result was $18.7 million, down 29.27% from the prior year.
  • Revenue grew to $14.4 million in Q1 2026 per OABI's latest filing, from $8.4 million in the prior quarter.
  • Over five years, Revenue peaked at $35.3 million in Q4 2022 and troughed at $2.2 million in Q3 2025.
  • A 5-year average of $9.0 million and a median of $6.9 million in 2023 frame the typical range for Revenue.
  • The sharpest annual moves came in 2023 and 2026: Revenue tumbled 86.36% in 2023, then surged 247.3% in 2026.
  • A 5-year view of Revenue shows it stood at $35.3 million in 2022, then plunged by 86.36% to $4.8 million in 2023, then surged by 124.06% to $10.8 million in 2024, then decreased by 22.47% to $8.4 million in 2025, then soared by 72.24% to $14.4 million in 2026.
  • Business Quant data shows OABI's Revenue at $14.4 million in Q1 2026, $8.4 million in Q4 2025, and $2.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 OmniAb 294.96 Mn 252.00 Mn 14.41 Mn 14.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.43 Mn
Dec 31, 2025 8.38 Mn
Sep 30, 2025 2.24 Mn
Jun 30, 2025 3.90 Mn
Mar 31, 2025 4.15 Mn
Dec 31, 2024 10.80 Mn
Sep 30, 2024 4.17 Mn
Jun 30, 2024 7.61 Mn
Mar 31, 2024 3.80 Mn
Dec 31, 2023 4.82 Mn
Sep 30, 2023 5.48 Mn
Jun 30, 2023 6.95 Mn
Mar 31, 2023 16.92 Mn
Dec 31, 2022 35.35 Mn
Sep 30, 2022 6.91 Mn
Jun 30, 2022 7.20 Mn
Mar 31, 2022 9.60 Mn